211 related articles for article (PubMed ID: 31116890)
21. Merkel Cell Carcinoma Therapeutic Update.
Cassler NM; Merrill D; Bichakjian CK; Brownell I
Curr Treat Options Oncol; 2016 Jul; 17(7):36. PubMed ID: 27262710
[TBL] [Abstract][Full Text] [Related]
22. Caring for Patients Treated With Checkpoint Inhibitors for the Treatment of Metastatic Merkel Cell Carcinoma.
Rubin KM; Hoffner B; Bullock AC
Semin Oncol Nurs; 2019 Oct; 35(5):150924. PubMed ID: 31514991
[TBL] [Abstract][Full Text] [Related]
23. Merkel cell carcinoma: recent insights and new treatment options.
Schrama D; Ugurel S; Becker JC
Curr Opin Oncol; 2012 Mar; 24(2):141-9. PubMed ID: 22234254
[TBL] [Abstract][Full Text] [Related]
24. Molecular characteristics and potential therapeutic targets in Merkel cell carcinoma.
Mauzo SH; Ferrarotto R; Bell D; Torres-Cabala CA; Tetzlaff MT; Prieto VG; Aung PP
J Clin Pathol; 2016 May; 69(5):382-90. PubMed ID: 26818033
[TBL] [Abstract][Full Text] [Related]
25. How we treat Merkel cell carcinoma: within and beyond current guidelines.
Park SY; Doolittle-Amieva C; Moshiri Y; Akaike T; Parvathaneni U; Bhatia S; Zaba LC; Nghiem P
Future Oncol; 2021 Apr; 17(11):1363-1377. PubMed ID: 33511866
[TBL] [Abstract][Full Text] [Related]
26. Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.
Amaral T; Leiter U; Garbe C
Rev Endocr Metab Disord; 2017 Dec; 18(4):517-532. PubMed ID: 28916903
[TBL] [Abstract][Full Text] [Related]
27. Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival.
Vandeven N; Lewis CW; Makarov V; Riaz N; Paulson KG; Hippe D; Bestick A; Doumani R; Marx T; Takagishi S; Chan TA; Choi J; Nghiem P
Clin Cancer Res; 2018 Feb; 24(4):963-971. PubMed ID: 29246939
[No Abstract] [Full Text] [Related]
28. Merkel cell carcinoma: emerging biology, current approaches, and future directions.
Tothill R; Estall V; Rischin D
Am Soc Clin Oncol Educ Book; 2015; ():e519-26. PubMed ID: 25993218
[TBL] [Abstract][Full Text] [Related]
29. Merkel cell carcinoma: Do you know your guidelines?
Miles BA; Goldenberg D;
Head Neck; 2016 May; 38(5):647-52. PubMed ID: 26716756
[TBL] [Abstract][Full Text] [Related]
30. Merkel cell carcinoma: current status of targeted and future potential for immunotherapies.
Aldabagh B; Joo J; Yu SS
Semin Cutan Med Surg; 2014 Jun; 33(2):76-82. PubMed ID: 25085666
[TBL] [Abstract][Full Text] [Related]
31. [Possible immunotherapies of skin cancers].
Lengyel LZS; Gyulai GYR
Magy Onkol; 2019 Sep; 63(3):239-245. PubMed ID: 31538441
[TBL] [Abstract][Full Text] [Related]
32. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.
Goh G; Walradt T; Markarov V; Blom A; Riaz N; Doumani R; Stafstrom K; Moshiri A; Yelistratova L; Levinsohn J; Chan TA; Nghiem P; Lifton RP; Choi J
Oncotarget; 2016 Jan; 7(3):3403-15. PubMed ID: 26655088
[TBL] [Abstract][Full Text] [Related]
33. Merkel cell carcinoma: An update and review: Current and future therapy.
Tello TL; Coggshall K; Yom SS; Yu SS
J Am Acad Dermatol; 2018 Mar; 78(3):445-454. PubMed ID: 29229573
[TBL] [Abstract][Full Text] [Related]
34. T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options.
Gehrcken L; Sauerer T; Schaft N; Dörrie J
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445385
[TBL] [Abstract][Full Text] [Related]
35. Current and preclinical treatment options for Merkel cell carcinoma.
Celikdemir B; Houben R; Kervarrec T; Samimi M; Schrama D
Expert Opin Biol Ther; 2023; 23(10):1015-1034. PubMed ID: 37691397
[TBL] [Abstract][Full Text] [Related]
36. Merkel Cell Carcinoma: Current Issues Regarding Diagnosis, Management, and Emerging Treatment Strategies.
Brummer GC; Bowen AR; Bowen GM
Am J Clin Dermatol; 2016 Feb; 17(1):49-62. PubMed ID: 26596990
[TBL] [Abstract][Full Text] [Related]
37. Update on the biology and clinical management of Merkel cell carcinoma.
Thakuria M; LeBoeuf NR; Rabinowits G
Am Soc Clin Oncol Educ Book; 2014; ():e405-10. PubMed ID: 24857131
[TBL] [Abstract][Full Text] [Related]
38. Avelumab: A Novel Anti-PD-L1 Agent in the Treatment of Merkel Cell Carcinoma and Urothelial Cell Carcinoma.
Teets A; Pham L; Tran EL; Hochmuth L; Deshmukh R
Crit Rev Immunol; 2018; 38(3):159-206. PubMed ID: 30004857
[TBL] [Abstract][Full Text] [Related]
39. Merkel cell carcinoma - recent advances in the biology, diagnostics and treatment.
Czapiewski P; Biernat W
Int J Biochem Cell Biol; 2014 Aug; 53():536-46. PubMed ID: 24811434
[TBL] [Abstract][Full Text] [Related]
40. In transit recurrence of Merkel cell carcinoma associated with polyarthritis effectively treated with immunocryosurgery.
Voulgari PV; Gaitanis G; Markatseli TE; Kempf W; Bassukas ID
Acta Derm Venereol; 2014 Nov; 94(6):739-40. PubMed ID: 24764027
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
